62.30
Schlusskurs vom Vortag:
$64.29
Offen:
$63.42
24-Stunden-Volumen:
2.37M
Relative Volume:
0.38
Marktkapitalisierung:
$11.29B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$-302.91M
KGV:
-36.26
EPS:
-1.7182
Netto-Cashflow:
$-219.93M
1W Leistung:
-0.02%
1M Leistung:
+18.97%
6M Leistung:
+18.36%
1J Leistung:
-23.56%
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TEM
Tempus Ai Inc
|
62.20 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
VEEV
Veeva Systems Inc
|
263.37 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
61.63 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
66.36 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HQY
Healthequity Inc
|
94.11 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Underperform |
| 2026-04-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral - Investing.com
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com UK
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Best Artificial Intelligence Stocks To ConsiderSeptember 7th - MarketBeat
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility With A 21.6% Revenue Growth - DirectorsTalk Interviews
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - Quiver Quantitative
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Artificial Intelligence Stocks Worth WatchingSeptember 3rd - MarketBeat
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - Yahoo Finance
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald initiates Tempus AI stock with overweight rating - Investing.com
Cantor Fitzgerald Initiates Tempus AI at Overweight With $80 Price Target - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
Cathie Wood's Investment Moves on September 1! Significantly Increased Stake in Rocket Lab, Reduced Holdings in Tempus AI - Moomoo
Tempus AI Inc (Derivatives) to Euro Price Today | Live TEM to EUR Converter & Exchange Rate - CryptoRank
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares - Benzinga
Tempus AI Director Nadja West Sells 3,000 Class A Shares Under Rule 10b5-1 Plan - Kalkine Media
Nadja West Sells 3,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI (TEM) director sells 3K shares, still holds 31,981 - Stock Titan
Tempus AI Inc (Derivatives) to Japanese Yen Price Today | Live TEM to JPY Converter & Exchange Rate - CryptoRank
Tempus AI (NASDAQ:TEM) Shares Gap UpShould You Buy? - MarketBeat
Tempus AI stock upgraded at Piper Sandler (TEM:NASDAQ) - Seeking Alpha
Tempus AI shares rise 2.7% following analyst actions - Yahoo Finance
Tempus AI Inc (Derivatives) to United States Dollar Price Today | Live TEM to USD Converter & Exchange Rate - CryptoRank
Tempus AI stock rises on Piper Sandler upgrade to Overweight By Investing.com - Investing.com Nigeria
Tempus AI stock rises on Piper Sandler upgrade to Overweight - Investing.com
Tempus AI Inc (Derivatives) to Russian Ruble Price Today | Live TEM to RUB Converter & Exchange Rate - CryptoRank
Tempus AI Inc (Derivatives) to Chinese Yuan Price Today | Live TEM to CNY Converter & Exchange Rate - CryptoRank
Piper Sandler upgrades Tempus AI stock rating on acquisition benefits - Investing.com
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):